[1] This risk is significantly higher in patients who also take insulin or sulfonylureas
00:04:32 Vickie Danaher So GLP-1 agonist medications activate these same receptors, helping people feel full sooner, staying fuller longer, and ultimately eating less
Formulations may vary based on provider recommendations and individual patient needs
What if these agents are psychiatric drugs that are masquerading as weight-loss drugs? Alzheimers disease Alzheimers is a progressive neurodegenerative disorder characterized primarily by problems with memory and cognition
The anti-thyroid effect of L-carnitine is based on its ability to inhibit thyroid hormone entry into the nucleus of hepatocytes, neurons, and fibroblasts (186, 210)
GLP-1 drugs likely to be helpful for additional indications October 22, 2025 Summary: New GLP-1 and related drugs are likely to become available over the next 3-5 years, and this drug class will likely be approved for additional indications